Researchers

Guojun Chen

Guojun Chen, Ph.DDr. Chen’s lab focuses on engineering intelligent biomaterials for drug delivery, with the ultimate goal towards precision medicine. They are also interested in understanding and exploiting the interactions between biomaterials and biological systems for therapeutic applications.

Learn more

 

 

Josée Dostie

Josée Dostie, Ph.DThe Dostie lab is working towards defining how the human genome is organized in three-dimensions, and identifying mechanisms that regulate spatial chromatin organization. We are applying genomics and molecular biology approaches to understand how genome folding impinges on gene expression in normal and diseased tissues such as in cancers. Learn more

Thomas Duchaine

Thomas Duchaine, Ph.D.Dr. Duchaine’s group focuses on the RNA- interference (RNAi) pathways, such as the diverse endogenous RNAi pathways and microRNA-mediated silencing. They examine the impact of these gene silencing mechanisms on the regulation of gene networks and their roles in cancer.

Learn more

Vincent Giguère

Vincent Giguère, Ph.DThe Giguère lab studies the role of nuclear receptors in development, physiology and diseases, especially in hormone-dependent cancers.


Learn more

Philippe Gros

Philippe Gros, Ph.DDr. Gros uses genetic analysis in mutant mouse models and in human patients cohorts to identify the molecular pathways and proteins required for protection against infections and whose sustained activation leads to chronic inflammation.

Sidong Huang

Sidong Huang, Ph.DDr. Huang’s group uses functional genomic tools to study cancer-relevant pathways and to guide cancer therapy. They aim to identify mechanisms of drug resistance and to uncover cancer dependencies that can be exploited therapeutically.
Learn more

 

Lawrence Kazak

Lawrence Kazak, Ph.DThe central theme of the Kazak lab is the molecular control of mammalian energy metabolism and its influence on physiology. The lab uses genetic and biochemical approaches in purified organelles, cultured cells and genetically engineered mice to investigate the control of thermogenic pathways in brown adipocytes that support energy expenditure.

Learn more

Luke McCaffrey

Luke McCaffrey, Ph.DDr. McCaffrey’s lab addresses fundamental questions in cell biology to understand mechanisms of breast cancer initiation and progression. His lab utilizes animal models, 3D organoids, and patient-derived tissue to interrogate dynamic behaviors between normal or cancer cells and their microenvironment. A goal of this research is to understand how cell and tissue organization influence the growth and invasive properties in cancer, to improve predictive, preventative, and therapeutic options.

Learn more

William Muller

William Muller, Ph.DDr. Muller's lab develops genetically engineered mouse models (GEMMs) to investigate mammary tumourigenesis, tumour progression and metastasis. Through combining GEMMs with molecular and cellular techniques, bioinformatic approaches and analysis of clinical samples, they identify critical signaling pathways and potential therapeutic targets in breast cancer, focusing on aggressive luminal tumours and those driven by the oncogene ErbB2/HER2.

Learn more

Alain Nepveu

Alain Nepveu, Ph.D.Dr Nepveu's group investigates how alterations in DNA repair and DNA damage responses contribute to the initiation and progression of cancer. The group is looking at how certain cancer cells become dependent on the base excision repair pathway, and how efficient base excision repair can enable cancer cells to resist radiotherapy and chemotherapy. One goal is to identify "druggable" biochemical activities that are essential to cancer cells, but dispensable to normal cells, in order to develop novel therapeutics.

Learn more

Morag Park

Morag Park, Ph.DDr. Morag Park’s lab focuses on: 1) The molecular and cellular biology of the receptor tyrosine kinase and proto-oncogene MET, its functions and regulation in normal cells and malignant cells; 2) The composition, organization and functional roles of the tumour microenvironment, particularly in triple negative breast cancer (TNBC). By integrating cutting edge cellular, transgenic and patient-derived models with unique biobanks of breast cancer patient samples, they uncover key mechanisms involved in tumourigenesis, tumour progression and drug resistance.

Learn more

Arnim Pause

Arnim Pause, Ph.DDr. Pause’s group studies cancer-relevant signalling pathways involved in energy metabolism and cell surface receptor trafficking

Learn more

Jerry Pelletier

Jerry Pelletier, Ph.DDr. Pelletier applies chemical biology and genetic approaches to dissect and target vulnerabilities in the translation initiation pathway. Insight gained from these studies will help better understand the regulation of tumor intrinsic and extrinsic survival processes.

Learn more

Daniela Quail

Daniel Quail, Ph.DDr. Quail’s lab studies the role of the tumor microenvironment during cancer initiation and progression. Their primary interest is the myeloid compartment in tumor immunology.

Learn more

Peter Siegel

Peter Siegel, Ph.DThe Siegel lab is focused on delineating mechanisms that control cancer cells' ability to metastasize to different organs and tissues in the body. Our research investigates how cancer cells interact with the distinct microenvironments to form metastases in sites like the bone, lungs, liver or brain. We work to identify functionally important and clinically validated mediators of the metastatic process that can be targeted through the generation of novel therapeutic agents.


Learn more

Nahum Sonenberg

Nahum Sonenberg, Ph.DDr. Sonenberg’s research focuses on the molecular basis of the control of protein synthesis in eukaryotic cells and its importance in cancer and neurological diseases. Our research has identified various mRNA translation factors involved in the control of protein synthesis along with their integration with several key signalling pathways, we believe targeting these pathways should facilitate the design of novel therapeutic.
Learn more

Jose Teodoro

Jose Teodoro, Ph.DTeodoro’s research program aims to identify the molecular pathways that limit tumour growth and to delineate the mechanisms by which they become subverted in cancer.
Learn more

Michel Tremblay

Michel Tremblay, Ph.DIn order to understand and find cures for human diseases, Dr Tremblay's lab focuses on protein tyrosine phosphatases (PTPases), which play an essential role in many biological and pathological processes. The lab is aiming to develop new treatments for a broad range of human diseases such as diabetes, obesity, spinal cord injury and infectious diseases as well as diverse cancers.

Learn more

Logan Walsh

Logan Walsh, Ph.DDr Walsh's lab focuses on using translational genetics and immunogenomics to develop personalized medicine strategies.

Learn more

Ian Watson

Ian Watson, Ph.DDr. Ian Watson's research focuses on understanding how mutated genes identified in next-generation sequencing studies promote cutaneous melanoma disease progression by modulating the response to targeted therapies and immune checkpoint inhibitors. To address this challenge, his lab utilizes an inter-disciplinary approach combining unbiased molecular characterization of melanoma tumors, rapid development of preclinical models using genome-editing technology, and bioinformatics tools.

Learn more

Yojiro Yamanaka

Yojiro Yamanaka, Ph.DDr. Yamanaka’s group studies the mechanisms regulating epithelial morphogenesis in development and cancer. Using mouse models and in vitro 3D culture, they investigate early events of ovarian cancer and peritoneal metastasis.

Learn more

George Zogopoulos

George Zogopoulos, MD, Ph.DDr. George Zogopoulos’ research focuses on the genetics and oncogenomics of pancreaticobiliary cancers.

Learn more

 

Back to top